Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedling and Latanoprost in Acrofacial Vitiligo
NCT03611348Phase 3Unknown
- Sponsor
- Sohag University
- Start
- Sep 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of latanoprost ophthalmic solution 0.005% (TearClear TC-002) in Vitiligo, sponsored by Sohag University. Status: unknown.
02
Drugs
latanoprost ophthalmic solution 0.005% (TearClear TC-002)
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT03611348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03611348.